These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10707531)

  • 1. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity].
    Borisova EV
    Mikrobiol Z; 1999; 61(6):36-41. PubMed ID: 10707531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The inductive immunosuppressive activity of the lipopolysaccharide from Shigella sonnei R forms].
    Borisova EV
    Mikrobiol Z; 1998; 60(3):63-9. PubMed ID: 9785801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunosuppressive activity of filtrates of the culture broth from nonvirulent salmonellae].
    Molozhavaia OS; Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(2):73-8. PubMed ID: 9221061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunobiological properties of the lipopolysaccharides of bacteria in the genus Shigella with contrasting virulence and their chemically modified analogs].
    Borisova EV
    Mikrobiol Z; 1999; 61(4):64-71. PubMed ID: 10565153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of shigellae on delayed hypersensitivity in mice infected by different routes].
    Borisov VA; Borisova EV; Solov'eva GA
    Mikrobiol Z; 1994; 56(3):55-9. PubMed ID: 7952228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive components of extracellular lipopolysaccharide highly virulent strain Salmonella typhimurium 1468].
    Molozhavaia OS; Borisova EV
    Mikrobiol Z; 2002; 64(3):75-80. PubMed ID: 12190039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipopolysaccharides of Shigella sonnei].
    Borisova EV; Borisov VA
    Prikl Biokhim Mikrobiol; 2000; 36(5):597-602. PubMed ID: 11042887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of the structural parts of bacterial lipopolysaccharide in its direct immunosuppressive activity].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):22-5. PubMed ID: 10356729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunomodulating properties of the filtrates of Klebsiella culture broth and the nature of the immunomodulating factor].
    Borisova EV; Polishchuk EI; Sel'nikova OP; Mishina LN; Borisov VA
    Mikrobiol Z; 1996; 58(6):55-62. PubMed ID: 9064073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressive activity of chemically modified lipopolysaccharide of Shigella sonnei.
    Vikström EV
    Immunol Lett; 2002 Jan; 80(1):15-9. PubMed ID: 11716960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Separation of Shigella enterotoxin and immunosuppression factors].
    Borisov VA
    Mikrobiol Zh (1978); 1988; 50(1):77-80. PubMed ID: 3074243
    [No Abstract]   [Full Text] [Related]  

  • 13. Components with potential immunosuppressive activity in lipopolysaccharide of laboratory Pseudomonas aeruginosa strains.
    Vikström EV
    Immunol Lett; 2003 Jan; 85(1):29-33. PubMed ID: 12505193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive action of lipopolysaccharide S- and R-forms of Salmonella and the role of lipid A].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (6):20-3. PubMed ID: 9949494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunosuppressive activity of Streptococcus aureus peptidoglycan].
    Posur VK; Borisova EV; Furtat IM; Lolo AA; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):56-8. PubMed ID: 7778377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inhibition of the cellular immune response by Pseudomonas aeruginosa extracts].
    Borisova VA; Furtat IM; Zgonnik VV; Borisova EV; Lolo AA; Shilina IuV
    Mikrobiol Zh (1978); 1993; 55(2):82-7. PubMed ID: 8497204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive properties of virulent Shigella strains].
    Borisova EB
    Mikrobiol Z; 2000; 62(1):64-72. PubMed ID: 11300086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipopolysaccharide changes in smooth-type avirulent Shigella in comparison with initial virulent strains].
    Nikolaeva AI; Nastichkin IA; Kabanova EA; Lapina EB; Krukovets IL
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):15-8. PubMed ID: 1441805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Candida albicans mannan-specific downregulatory cell populations with divergent concentrations of monophosphoryl lipid A and intact lipopolysaccharide in vitro abrogates their effect on delayed hypersensitivity.
    Domer JE; Asherson GL; Li S
    Cell Immunol; 1996 Jan; 167(1):8-17. PubMed ID: 8548849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of the immunosuppressivity of virulent Shigella to the structure of O antigen].
    Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):63-7. PubMed ID: 2452538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.